Massachusetts To Expand Grant Funded Office-Based Addiction Treatment Services Beyond Buprenorphine

Massachusetts is expanding its grant-funded, office-based addiction treatment (OBAT) program to more types of addiction disorders. The state previously funded office-based opioid treatment with buprenorphine, and is now expanding office-based services to alcohol and stimulant use disorders treated with injectable naltrexone. OBAT organizations that wish to offer methadone as an OUD maintenance treatment can partner with an existing licensed opioid treatment program (OTP) deliver on-site methadone treatment, or OBAT organizations can pursue their own OTP license and certification.

The expansion request for response (RFR BD-23-1031-ADMIN-ADM07-78592) was released on August 19 . . .